In short, based on these databases, this study explored the correlation between the expression of SLCO4A1 and prognosis in COAD patients and found that SLCO4A1 was a valuable biomarker for evaluating prognosis in patients with COAD. This evidence concerns the gene SLCO4A1 and colon adenocarcinoma.